Skip to main content
. 2021 Mar 18;10(2):815–825. doi: 10.1007/s40121-021-00431-9

Table 3.

Estimated results on the efficacy of remdesivir treatment

Outcomes Estimate
(95% CI)
COVID-19 death
 Relative risk ratio

0.695

(0.491, 0.934)

 Risk difference

21.0%

(17.2, 25.6%)

 NNT

133.3

(112.5, 158.0)

Recovery and discharge
 Relative risk ratio

1.343

(1.007, 1.792)

 Risk difference

22.0%

(8.9, 54.7%)

 NNT

127.3

(116.5, 139.0)